Page last updated: 2024-11-03

propranolol and Dysesthesia

propranolol has been researched along with Dysesthesia in 8 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"In 61 out-patients with essential hypertension, grade I or II, propranolol was administered alone in increasing doses (3 x 40 mg/d or 3 x 80 mg/d) or, if there was insufficient response, with a double or triple combination consisting additionally of spironolactone (50 mg/d)-thiabutazide (5 mg/d) and dihydralazine (3 x 25 mg/d)."9.04[Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. ( Ebel, H; Klaus, D; Lübke, H; Witzgall, H; Zehner, J, 1978)
"In 61 out-patients with essential hypertension, grade I or II, propranolol was administered alone in increasing doses (3 x 40 mg/d or 3 x 80 mg/d) or, if there was insufficient response, with a double or triple combination consisting additionally of spironolactone (50 mg/d)-thiabutazide (5 mg/d) and dihydralazine (3 x 25 mg/d)."5.04[Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. ( Ebel, H; Klaus, D; Lübke, H; Witzgall, H; Zehner, J, 1978)
"A patient developed severe anxiety, moodswing, depression, and thinking disorder 24 hours after abruptly stopping oxazepam, of which he had taken 30 mg 3 times a day for two months, for anxiety and panic attacks."3.66Abstinence syndrome from therapeutic doses of oxazepam. ( Kulik, AV; Wilbur, R, 1983)
"Persistent cutaneous dysesthesias were present in seven patients, in most cases many years after completion of involution."1.62Persistent dysesthesias in involuted infantile hemangiomas: An uncommon complication in a common condition. ( Antaya, RJ; Braun, M; Frieden, IJ; Kohn, LL; Mancini, AJ; Metry, D, 2021)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19907 (87.50)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Braun, M1
Metry, D1
Frieden, IJ1
Antaya, RJ1
Mancini, AJ1
Kohn, LL1
Schneck, DW1
Scadding, JW1
Wall, PD1
Parry, WCB1
Brooks, DM1
Wilbur, R1
Kulik, AV1
Ebel, H1
Lübke, H1
Klaus, D1
Zehner, J1
Witzgall, H1
Stephen, SA1
Clark, DW1
Goldberg, LI1
Kernohan, RJ1

Trials

3 trials available for propranolol and Dysesthesia

ArticleYear
Clinical trial of propranolol in post-traumatic neuralgia.
    Pain, 1982, Volume: 14, Issue:3

    Topics: Adult; Arm; Arm Injuries; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middl

1982
[Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1978, Oct-20, Volume: 103, Issue:42

    Topics: Anxiety; Bradycardia; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydroch

1978
Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol.
    Annals of internal medicine, 1972, Volume: 76, Issue:4

    Topics: Antihypertensive Agents; Anxiety; Aspartate Aminotransferases; Blood Pressure; Clinical Trials as To

1972

Other Studies

5 other studies available for propranolol and Dysesthesia

ArticleYear
Persistent dysesthesias in involuted infantile hemangiomas: An uncommon complication in a common condition.
    Pediatric dermatology, 2021, Volume: 38, Issue:5

    Topics: Administration, Cutaneous; Adolescent; Adult; Child; Child, Preschool; Hemangioma; Hemangioma, Capil

2021
Therapeutic rounds at the Milton S. Hershey Medical Center: central nervous system toxicity caused by lidocaine.
    Clinical therapeutics, 1983, Volume: 5, Issue:6

    Topics: Cognition Disorders; Confusion; Drug Interactions; Heart Failure; Humans; Lidocaine; Male; Middle Ag

1983
Abstinence syndrome from therapeutic doses of oxazepam.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1983, Volume: 28, Issue:4

    Topics: Adult; Anxiety; Depression; Depressive Disorder; Diazepam; Fasciculation; Fear; Humans; Male; Oxazep

1983
Unwanted effects of propranolol.
    The American journal of cardiology, 1966, Volume: 18, Issue:3

    Topics: Blood Cell Count; Blood Urea Nitrogen; Bradycardia; Drug Eruptions; Enzymes; Heart Failure; Humans;

1966
Propranolol in paroxysmal ventricular tachycardia.
    British heart journal, 1966, Volume: 28, Issue:4

    Topics: Aged; Heart Ventricles; Humans; Male; Paresthesia; Propranolol; Sympatholytics; Syncope; Tachycardia

1966